Colin Edward Rowlings

Title: Colin Edward Rowlings: Innovator in Pharmaceutical Compositions

Introduction

Colin Edward Rowlings is a notable inventor based in Encinitas, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions and methods for treating various diseases. With a total of 2 patents, Rowlings has demonstrated his expertise and commitment to innovation in the medical field.

Latest Patents

Rowlings' latest patents include groundbreaking inventions that focus on compositions and methods for preparing and using them. One of his patents relates to compositions that can treat or prevent diseases through the administration of specific formulations. Another patent involves derivatives of N-(arylamino) sulfonamides, which serve as inhibitors of MEK. This invention highlights the importance of crystalline polymorphic forms that exhibit unique profiles, making them valuable in the treatment of cancer, hyperproliferative diseases, and inflammatory conditions.

Career Highlights

Colin Edward Rowlings is currently associated with Ardea Biosciences, Inc., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing innovative solutions that address critical health issues. Rowlings' dedication to his field is evident in the patents he has secured, which reflect his innovative approach to drug development.

Collaborations

Rowlings has collaborated with esteemed colleagues such as Barry D Quart and Jean-Michel Andre Vernier. These partnerships have further enriched his research and contributed to the advancement of pharmaceutical sciences.

Conclusion

Colin Edward Rowlings stands out as a prominent inventor in the pharmaceutical industry, with a focus on innovative compositions and methods for disease treatment. His contributions are paving the way for new therapeutic options and improving patient outcomes.